Thalassaemia: vizsgálatok itt: Görögország
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
- Where
- Athens, Thessaloniki
- Életkor
- 1 év to 17 év
- People
- 54 worldwide
- Run by
- Agios Pharmaceuticals, Inc.
See details and how to joinNCT07506863 · EU 2025-524707-71-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
- Where
- Athens
- Életkor
- 1 év to 17 év
- People
- 45 worldwide
- Run by
- Agios Pharmaceuticals, Inc.
See details and how to joinNCT07517133 · EU 2025-524706-15-00 - 3. fázisTaking peopleA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Athens, Larissa, Patras, Thessaloniki
- Életkor
- 2 év and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00 - 2. fázisTaking peopleStudy of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- Where
- Athens
- Életkor
- 6 év to 17 év
- People
- 99 worldwide
- Run by
- Celgene
See details and how to joinNCT04143724 · EU 2022-502499-22-00 - 3. fázisTaking peopleA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Athens, Rio Patras, Thessaloniki
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - No phaseCsak meghívásosUse of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients
- Where
- Athens
- Életkor
- 18 év and over
- People
- 30
- Run by
- University Research Institute for the Study of Genetic & Malignant Disorders in Childhood
See details and how to joinNCT07055503 - 2. fázisTaking peopleA Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
- Where
- Athens, Chaïdári, Ioannina, Larissa, Patra, Thessaloniki
- Életkor
- 18 év to 64 év
- People
- 90 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT05693909 · EU 2023-507396-21-00 - No phaseTaking peopleStudy of the Role of Genetic Modifiers in Hemoglobinopathies
- Where
- Athens, Larissa
- Életkor
- 2 év and over
- People
- 30 000 worldwide
- Run by
- Cyprus Institute of Neurology and Genetics
See details and how to joinNCT05799118